In addition to ABCA1, gilteritinib also suppressed mRNA expression of another important cholesterol efflux protein ATP-binding cassette subfamily G member 1 (ABCG1) (Fig. 3E); in KM plotter online database, lung cancer patients with high ABCG1 expression have longer survival time than those with low ABCG1 expression (Fig. 3F), suggesting that patients with highly expressed ABCG1 may have good response to chemotherapy. Here, ABCA1 is linked to lung carcinoma.